“Breathing supplemental oxygen opens up the gates of the tumor fortress and wakes up ‘sleepy’ anti-tumor cells, enabling these soldiers to enter the fortress and destroy it,”Dr. Sitkovsky explains.
Northeastern University Distinguished Professor Kim Lewis and his team’s pioneering research presenting a new antibiotic that kills pathogens without encountering any detectable resistance has captured headlines worldwide and drawn widespread praise from the scientific community.
In preparation for their upcoming graduate co-op experience, second year students in the Biotechnology PSM Program attended a career panel event on October 22 in Northeastern’s Alumni Center. Jay Duffer, Senior Scientist at Momenta Pharmaceuticals; Ruchita Chawla, Research Associate Protein Engineer at Manus Biosynthesis, and Srishti Gurnani, Research Associate at Momenta Pharmaceuticals–all graduates of the […]
Career Services‘ extensive career search support including an array of online tools, an online database, workshops, job fairs, strong alumni networks, plus an Employer in Residence program has earned Northeastern recognition by Best Colleges and The Princeton Review.
Bacteria are a pervasive bunch so why have only a handful been identified so far? Supported by a Tier 1 Interdisciplinary Research Grant, Drs. Slava Epstein and Edgar Goluch create a device that is up to the task.
Sometimes the best solutions are the simplest ones. “It’s an absolutely new concept for treating cancer.”
A quarter century ago, Barry Karger and his team published research in the journal Proceedings of the National Academy of Sciences that would help enable scientists to sequence the human genome.
Lyme is one of those puzzling chronic diseases: while people that are treated by antibiotics shortly after they’re bitten by the tic get cured, about 10 to 20 percent don’t. Why not?
ScanDrop is a portable instrument no bigger than a shoebox that has the capacity to detect a variety of biological specimen.
Dr. John Engen utilizes hydrogen exchange mass spectrometry to make confirmation of biosimilars a feasible task. His work was recently highlighted in the journal Biopharm International.